bluebird bio, Inc.

    bluebird bio, Inc.

    NNASDAQ:BLUE
    4.97
    USD
    0.00
    (0.00%)
    bluebird bio, Inc.
    NASDAQ:BLUE
    (Nasdaq Stock Market)

    Recent

    price

    4.97

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    USD
    0.77
    0.3
    32.15
    19.15
    8.12
    3.3
    16.28
    20.98
    - -
    - -
    1.07
    0.92
    5.37
    8.65
    10.7
    Revenue per Share
    -13.68
    -20.75
    -40.34
    -36.7
    -96.21
    -141.35
    -154.19
    -213.57
    -286.14
    -199.01
    -240.32
    -58.62
    -38.59
    -24.84
    -20.59
    Basic EPS, GAAP
    -11.07
    -19.21
    55.4
    -51.53
    -60.85
    -116.77
    -157.48
    -180.34
    -232.15
    -160.62
    -193.18
    -83.84
    -44.46
    -27.1
    -23.73
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -55.62
    -64.31
    -156.81
    -110.8
    -181.03
    -309.66
    -419.58
    -575.9
    -826.69
    -932.77
    -1,090.84
    -1,030.12
    -775.53
    -464.35
    -466.32
    Book Value per Share
    -48.84
    -50.93
    241.6
    338.97
    468.96
    448.24
    732
    714.47
    455.7
    432.63
    108.12
    31.51
    32.5
    -4.82
    -7.5
    Tangible Book Value per Share
    1
    1
    1
    1
    2
    2
    2
    3
    3
    3
    3
    4
    5
    10
    10
    Basic Weighted Avg Shares
    1
    - -
    20
    25
    14
    6
    35
    55
    - -
    - -
    4
    4
    29
    84
    104
    Sales/Revenue/Turnover
    -1,716.78
    -6,975.29
    -123.62
    -237.52
    -1,180.25
    -4,284.96
    -939.09
    -1,042.57
    - -
    - -
    -15,431.73
    -6,818.04
    -828.09
    -319.42
    -202.52
    Operating Margin (%)
    - -
    - -
    1
    4
    7
    10
    14
    17
    17
    19
    20
    8
    29
    61
    61
    Depreciation Expense
    -16
    -24
    -25
    -49
    -167
    -264
    -336
    -556
    -790
    -619
    -819
    -230
    -212
    -241
    -200
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    -1,768.48
    -6,961.76
    -125.47
    -191.61
    -1,184.62
    -4,281.19
    -947.42
    -1,018.02
    - -
    - -
    -22,375.15
    -6,403.73
    -718.42
    -287.23
    -192.39
    Profit Margin (%)
    27
    63
    177
    437
    484
    650
    1,227
    1,273
    929
    1,012
    184
    47
    82
    -167
    -141
    Working Capital
    - -
    - -
    - -
    - -
    62
    120
    155
    153
    171
    56
    66
    279
    224
    169
    39
    LT Debt
    -56
    -56
    152
    491
    850
    869
    1,623
    1,885
    1,285
    1,355
    374
    134
    195
    -32
    -58
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    ST Debt
    195
    189
    149
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    174
    169
    39
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    10
    10
    10
    Market Capitalization
    101
    81
    47

    Working Capital

    USD

    •

    in mil. unless spec.
    Sep'24
    Dec'24
    Mar'25
    Total Current Assets
    151
    155
    175
    Cash, Cash Equivalents & STI
    71
    62
    79
    Accounts Receivable, Net
    18
    14
    1
    Inventories
    54
    65
    83
    Total Current Liabilities
    296
    321
    315
    Payables & Accruals
    82
    113
    142
    ST Debt
    195
    189
    149
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -5.61%
    -40.49%
    -116.21%
    Free Cash Flow
    23.3%
    -11.69%
    7.59%
    Net Income, GAAP
    37.99%
    -11.1%
    13.59%
    Sales/Revenue/Turnover
    - -
    - -
    184.12%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    2
    7
    12
    8
    29
    2024
    19
    16
    11
    39
    84
    2025
    39
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    3.68
    -11.55
    -15.99
    - -
    -38.59
    2024
    -7.23
    -8.4
    -6.27
    - -
    -24.84
    2025
    -2.98
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business

    Company News

    • BLUE OWL MANAGED FUNDS LEAD $2.4 BILLION AI FACTORY FINANCING FOR IREN

    • BLUE OWL CAPITAL ANNOUNCES PRICING OF SENIOR NOTES OFFERING

    • BLUE OWL CAPITAL ANNOUNCES SENIOR NOTES OFFERING

    • FULTON FINANCIAL MERGES ITS BLUE FOUNDRY BANK SUBSIDIARY INTO FULTON BANK, N.A.

    • Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting

    • Intermedia Launches Cloud Calling for UNIVERGE BLUE with KDDI, Significantly Expanding Nationwide UCaaS Availability in Japan

    • ISS and Glass Lewis Support BIMIZCI's Case for Change at Medallion Financial. Both Recommend Stockholders Vote on the BLUE Proxy Card FOR Election of Two BIMIZCI Nominees to Medallion Board

    • BLUE OWL CAPITAL INC. INVESTOR ALERT: Haeggquist & Eck, LLP Announces Investigation of Blue Owl Capital Inc.'s Directors and Officers for Breach of Fiduciary Duties – OWL

    • BLUE WATER ACQUISITION CORP. IV ANNOUNCES LETTER OF INTENT FOR A PROPOSED ACQUISITION OF MAHA CAPITAL AB SUBSIDIARIES, CREATING A PUBLIC PLATFORM WITH VENEZUELAN ENERGY EXPOSURE AND HIGH-GROWTH AI FINTECH BUSINESS

    • FULTON FINANCIAL CORPORATION COMPLETES ACQUISITION OF BLUE FOUNDRY BANCORP

    • BLUE OWL CAPITAL INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Blue Owl Capital Inc.'s Directors and Officers for Breach of Fiduciary Duties – OWL

    • BLUE OWL CAPITAL CORPORATION II BOARD UNANIMOUSLY RECOMMENDS SHAREHOLDERS REJECT UNSOLICITED MINORITY OFFER FROM COX AND SABA

    • BLUE OWL CAPITAL INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Blue Owl Capital Inc.'s Directors and Officers for Breach of Fiduciary Duties – OWL

    • FULTON FINANCIAL CORPORATION AND BLUE FOUNDRY BANCORP ANNOUNCE REGULATORY APPROVALS AND ANTICIPATED MERGER CLOSING DATE

    • Leading Proxy Advisory Firms ISS and Glass Lewis Affirm Recommendation That LabGold Shareholders Vote ONLY the BLUE Proxy and Reject Dissident Attempt to Seize Control

    • BLUE OWL DEADLINE: ROSEN, A RANKED AND LEADING FIRM, Encourages Blue Owl Capital Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OWL

    • BLUE OWL DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Blue Owl Capital Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OWL

    • BLUE OWL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Blue Owl Capital Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OWL

    • BLUE OWL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Blue Owl Capital Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OWL

    • /R E P E A T -- BLUE MOON METALS TO BEGIN TRADING ON NASDAQ UNDER BMM AND APPOINTS PETER MADSEN TO THE BOARD OF DIRECTORS/